REFERENCES
- Research Subcommittee of the international Dry Eye Workshop. Research in Dry Eye. Ocul Surf 2007;5:179–193.
- Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995;21:221–232.
- Mertzanis P, Abetz L, Rajagopalan K et al. The relative burden of dry eye in patients’ lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci 2005;46:46–50.
- Miyawaki S, Nishiyama S. Classification criteria for Sjogren’s syndrome: sensitivity and specificity of criteria of the Japanese Ministry of Health and Welfare (1977) and criteria of European community (1993). Nippon Rinsho 1995; 53:2371–2375.
- Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004;23:762–770.
- Patel S, Farrell JC, Grierson DJ. A possible reason for the lack of symptoms in aged eyes with low tear stability. Optom Vis Sci 1990;67:733–734.
- Ozcura F, Aydin S, Helvaci MR. Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm 2007;15:389–393.
- Schiffman RM, Christianson MD, Jacobsen G et al. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000;118:615–621.
- Matsumoto Y, Dogru M, Goto E et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 2004;111:1115–1120.
- Vajpayee RB, Mukerji N, Tandon R et al. Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol 2003;87:1312–1316.
- del Castillo JM, de la Casa JM, Sardiña RC et al. Treatment of recurrent corneal erosions using autologous serum. Cornea 2002;21:781–783.
- Kojima T, Ishida R, Dogru M et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 2005;139:242–246.
- Noble BA, Loh RS, MacLennan S et al. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 2004;88:647–652.
- Tananuvat N, Daniell M, Sullivan LJ et al. Controlled study of the use of autologous serum in dry eye patients. Cornea 2001;20:802–806.
- Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009;27:158–167.
- Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 2003;22:640–650.
- Behrens A, Doyle JJ, Stern L et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 2006; 25:90–97.
- Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 2004;88:1467–1474.
- Tsubota K, Goto E, Fujita H et al. Treatment of dry eye by autologous serum application in Sjögren’s syndrome. Br J Ophthalmol 1999;83:390–395.
- Bradley JC, Bradley RH, McCartney DL et al. Serum growth factor analysis in dry eye syndrome. Clin Experiment Ophthalmol 2008;36:717–720.
- Hartwig D, Harloff S, Liu L et al. Epitheliotrophic capacity of a growth factor preparation produced from platelet concentrates on corneal epithelial cells: a potential agent for the treatment of ocular surface defects? Transfusion 2004;44:1724–1731.
- Koelwel C, Rothschenk S, Fuchs-Koelwel B et al. Alginate inserts loaded with epidermal growth factor for the treatment of keratoconjunctivitis sicca. Pharm Dev Technol 2008;13:221–231.